A new mRNA diagnostic tool developed at Stanford University and funded by BARDA and DARPA is bringing implantable biochip technology closer to reality. by Raul Diego The POC (point-of-care) diagnostics market stands at about $18.8 billion globally, according to recent market trends, and is expected to grow by a third to $24.1 […]

//